Part <b>Ⅴ</b> of database building: design of tumor characteristics module of colorectal cancer <b>Ⅱ</b>_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

WANG Xiaodong ¹ , LIU Jianbo ^1,2 ,  LI Li ¹

1. Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu 610041, P. R. China;
2. West China School of Medicine, Sichuan University, Chengdu 610041, P. R. China;

Corresponding?author：

LI Li, Email: drlili116@126.com

Keywords：

colorectal cancer; tumor characteristics; database; bigdata; tag; structure

DOI：

10.7507/1007-9424.202002045

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To elaborate constitute, definition, and interpretation of tumor characteristics module of colorectal cancer in the Database from Colorectal Cancer (DACCA) in the West China Hospital.Method The article was described in the words.Results The tumor features module of colorectal cancer in the DACCA included the precancerous lesion, cancer family, location of tumor, distance to the dentate line, morphology of tumor, size, position, happening and origination, differentiation, pathology of tumor, Ki-67 protein, obstruction, intussusception, perforation, pain, edema, and hemorrhage. The exact definitions of morphology of tumor, size, position, differentiation, pathology of tumor, Ki-67 protein and complication (included obstruction, intussusception, perforation, pain, edema, and hemorrhage), tag and structure, corrective precautions and update of these columns, and how to use these tumor characteristics in the DACCA when analysis was carried out were described in detail.Conclusion Through detailed description and specification of current tumor characteristics module of colorectal cancer in DACCA in West China Hospital, it can provide a reference for standardized treatment of colorectal cancer and also provide experiences for the peers who wish to build a colorectal cancer database.

Citation： WANG Xiaodong, LIU Jianbo, LI Li. Part Ⅴ of database building: design of tumor characteristics module of colorectal cancer Ⅱ. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2020, 27(4): 483-488. doi: 10.7507/1007-9424.202002045 Copy

1.	劉健博, 呂炘沂, 鄒雨恒, 等. 多周期新輔助化療聯合阿帕替尼對進展期直腸癌的療效評價: 基于 DACCA 數據庫的輔助研究. 中國普外基礎與臨床雜志, 2019, 26(6): 728-734.
2.	劉健博, 由屹先, 鄒雨恒, 等. 數據庫輔助研究: 結直腸癌新輔助治療的應用—基于 DACCA 的華西真實世界數據報道. 中國普外基礎與臨床雜志, 2019, 26(12): 1467-1475.
3.	汪曉東, 安麗珉, 李立. 數據庫研究第二部分: 結直腸癌的住院流程管理. 中國普外基礎與臨床雜志, 2019, 26(4): 469-475.
4.	汪曉東, 李立. 數據庫建設第一部分: 個人數據的標簽與結構化. 中國普外基礎與臨床雜志, 2019, 26(3): 335-342.
5.	汪曉東, 李立. 真實場景與大數據下的整體微創理念, 大幅提高結直腸癌遠期生存率. 中國普外基礎與臨床雜志, 2019, 26(1): 92-95.
6.	汪曉東, 李希, 何欣林, 等. 數據庫研究第一部分: 區域性醫療中心的結直腸癌與人群特征. 中國普外基礎與臨床雜志, 2019, 26(2): 212-220.
7.	汪曉東, 劉健博, 安麗珉, 等. 數據庫建設第四部分: 結直腸癌的術前專科檢查與評估的標簽與結構化. 中國普外基礎與臨床雜志, 2019, 26(11): 1337-1341.
8.	汪曉東, 劉健博, 安麗珉, 等. 數據庫研究第四部分: 結直腸癌的術前專科檢查與評估. 中國普外基礎與臨床雜志, 2019, 26(10): 1230-1238.
9.	汪曉東, 劉健博, 李立. 數據庫建設第三部分: 結直腸癌內外科合并癥及術前體質狀態的標簽與結構化. 中國普外基礎與臨床雜志, 2019, 26(9): 1110-1115.
10.	汪曉東, 劉健博, 張詩, 等. 數據庫研究第三部分: 結直腸癌的內外科合并癥及術前體質狀態. 中國普外基礎與臨床雜志, 2019, 26(8): 985-991.
11.	汪曉東, 呂炘沂, 黃明君, 等. 數據庫建設第二部分: 結直腸癌住院流程管理的標簽與結構化. 中國普外基礎與臨床雜志, 2019, 26(7): 852-855.
12.	于瑞璇, 何欣林, 張秋露, 等. 華西 DACCA 的輔助研究: 單獨的新輔助化療不會影響直腸癌術后近期的肛門功能. 中國普外基礎與臨床雜志, 2019, 26(5): 595-601.
13.	汪曉東, 劉健博, 李立. 數據庫建設第五部分: 結直腸癌的腫瘤特征—模塊的設計(一). 中國普外基礎與臨床雜志, 2020, 27(3): 345-349.
14.	Su MY, Ho YP, Hsu CM, et al. How can colorectal neoplasms be treated during colonoscopy? World J Gastroenterol, 2005, 11(18): 2806-2810.
15.	Wang YP, Guo PT, Zhu Z, et al. Macroscopic serosal classification of colorectal cancer and its clinical significance. Int J Clin Exp Med, 2015, 8(11): 20123-20134.
16.	Suenaga M, Fujimoto Y, Matsusaka S, et al. Perioperative FOLFOX4 plus bevacizumab for initially unresectable advanced colorectal cancer (NAVIGATE-CRC-01). Onco Targets Ther, 2015, 8: 1111-1118.
17.	Granero-Castro P, Mu?oz E, Frasson M, et al. Evaluation of mesorectal fascia in mid and low anterior rectal cancer using endorectal ultrasound is feasible and reliable: a comparison with MRI findings. Dis Colon Rectum, 2014, 57(6): 709-714.
18.	Issa N, Fenig Y, Khatib M, et al. Transanal endoscopic microsurgery combined with laparoscopic colectomy for synchronous colorectal tumors: a word of caution. J Laparoendosc Adv Surg Tech A, 2017, 27(6): 605-610.
19.	Nemanqani DM, Aftab K, Al-Malki SH, et al. Expression of epidermal growth factor receptor in colorectal adenocarcinoma and its correlation with clinicopathological factors. J Coll Physicians Surg Pak, 2018, 28(7): 527-531.
20.	Wei XB, Gao XH, Wang H, et al. More advanced or aggressive colorectal cancer is associated with a higher incidence of “high-grade intraepithelial neoplasia” on biopsy-based pathological examination. Tech Coloproctol, 2012, 16(4): 277-283.
21.	Li LT, Jiang G, Chen Q, et al. Ki67 is a promising molecular target in the diagnosis of cancer (review). Mol Med Rep, 2015, 11(3): 1566-1572.
22.	Dudley JC, Lin MT, Le DT, et al. Microsatellite instability as a biomarker for PD-1 blockade. Clin Cancer Res, 2016, 22(4): 813-820.
23.	Li X, Yao X, Wang Y, et al. MLH1 promoter methylation frequency in colorectal cancer patients and related clinicopathological and molecular features. PLoS One, 2013, 8(3): e59064.
24.	Goodenberger ML, Thomas BC, Riegert-Johnson D, et al. PMS2 monoallelic mutation carriers: the known unknown. Genet Med, 2016, 18(1): 13-19.

1. 劉健博, 呂炘沂, 鄒雨恒, 等. 多周期新輔助化療聯合阿帕替尼對進展期直腸癌的療效評價: 基于 DACCA 數據庫的輔助研究. 中國普外基礎與臨床雜志, 2019, 26(6): 728-734.
2. 劉健博, 由屹先, 鄒雨恒, 等. 數據庫輔助研究: 結直腸癌新輔助治療的應用—基于 DACCA 的華西真實世界數據報道. 中國普外基礎與臨床雜志, 2019, 26(12): 1467-1475.
3. 汪曉東, 安麗珉, 李立. 數據庫研究第二部分: 結直腸癌的住院流程管理. 中國普外基礎與臨床雜志, 2019, 26(4): 469-475.
4. 汪曉東, 李立. 數據庫建設第一部分: 個人數據的標簽與結構化. 中國普外基礎與臨床雜志, 2019, 26(3): 335-342.
5. 汪曉東, 李立. 真實場景與大數據下的整體微創理念, 大幅提高結直腸癌遠期生存率. 中國普外基礎與臨床雜志, 2019, 26(1): 92-95.
6. 汪曉東, 李希, 何欣林, 等. 數據庫研究第一部分: 區域性醫療中心的結直腸癌與人群特征. 中國普外基礎與臨床雜志, 2019, 26(2): 212-220.
7. 汪曉東, 劉健博, 安麗珉, 等. 數據庫建設第四部分: 結直腸癌的術前專科檢查與評估的標簽與結構化. 中國普外基礎與臨床雜志, 2019, 26(11): 1337-1341.
8. 汪曉東, 劉健博, 安麗珉, 等. 數據庫研究第四部分: 結直腸癌的術前專科檢查與評估. 中國普外基礎與臨床雜志, 2019, 26(10): 1230-1238.
9. 汪曉東, 劉健博, 李立. 數據庫建設第三部分: 結直腸癌內外科合并癥及術前體質狀態的標簽與結構化. 中國普外基礎與臨床雜志, 2019, 26(9): 1110-1115.
10. 汪曉東, 劉健博, 張詩, 等. 數據庫研究第三部分: 結直腸癌的內外科合并癥及術前體質狀態. 中國普外基礎與臨床雜志, 2019, 26(8): 985-991.
11. 汪曉東, 呂炘沂, 黃明君, 等. 數據庫建設第二部分: 結直腸癌住院流程管理的標簽與結構化. 中國普外基礎與臨床雜志, 2019, 26(7): 852-855.
12. 于瑞璇, 何欣林, 張秋露, 等. 華西 DACCA 的輔助研究: 單獨的新輔助化療不會影響直腸癌術后近期的肛門功能. 中國普外基礎與臨床雜志, 2019, 26(5): 595-601.
13. 汪曉東, 劉健博, 李立. 數據庫建設第五部分: 結直腸癌的腫瘤特征—模塊的設計(一). 中國普外基礎與臨床雜志, 2020, 27(3): 345-349.
14. Su MY, Ho YP, Hsu CM, et al. How can colorectal neoplasms be treated during colonoscopy? World J Gastroenterol, 2005, 11(18): 2806-2810.
15. Wang YP, Guo PT, Zhu Z, et al. Macroscopic serosal classification of colorectal cancer and its clinical significance. Int J Clin Exp Med, 2015, 8(11): 20123-20134.
16. Suenaga M, Fujimoto Y, Matsusaka S, et al. Perioperative FOLFOX4 plus bevacizumab for initially unresectable advanced colorectal cancer (NAVIGATE-CRC-01). Onco Targets Ther, 2015, 8: 1111-1118.
17. Granero-Castro P, Mu?oz E, Frasson M, et al. Evaluation of mesorectal fascia in mid and low anterior rectal cancer using endorectal ultrasound is feasible and reliable: a comparison with MRI findings. Dis Colon Rectum, 2014, 57(6): 709-714.
18. Issa N, Fenig Y, Khatib M, et al. Transanal endoscopic microsurgery combined with laparoscopic colectomy for synchronous colorectal tumors: a word of caution. J Laparoendosc Adv Surg Tech A, 2017, 27(6): 605-610.
19. Nemanqani DM, Aftab K, Al-Malki SH, et al. Expression of epidermal growth factor receptor in colorectal adenocarcinoma and its correlation with clinicopathological factors. J Coll Physicians Surg Pak, 2018, 28(7): 527-531.
20. Wei XB, Gao XH, Wang H, et al. More advanced or aggressive colorectal cancer is associated with a higher incidence of “high-grade intraepithelial neoplasia” on biopsy-based pathological examination. Tech Coloproctol, 2012, 16(4): 277-283.
21. Li LT, Jiang G, Chen Q, et al. Ki67 is a promising molecular target in the diagnosis of cancer (review). Mol Med Rep, 2015, 11(3): 1566-1572.
22. Dudley JC, Lin MT, Le DT, et al. Microsatellite instability as a biomarker for PD-1 blockade. Clin Cancer Res, 2016, 22(4): 813-820.
23. Li X, Yao X, Wang Y, et al. MLH1 promoter methylation frequency in colorectal cancer patients and related clinicopathological and molecular features. PLoS One, 2013, 8(3): e59064.
24. Goodenberger ML, Thomas BC, Riegert-Johnson D, et al. PMS2 monoallelic mutation carriers: the known unknown. Genet Med, 2016, 18(1): 13-19.

Previous Article
Ross-Konno 手術治療兒童主動脈瓣及瓣下狹窄的臨床療效
Next Article
Pancreatic neuroendocrine neoplasm: current status and advancement in imaging

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Part Ⅴ of database building: design of tumor characteristics module of colorectal cancer Ⅱ

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content